Bhavraj Khalsa, MD
Vascular & Interventional Radiology · Orange, CANPI 1588928378
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $246,296 of the $406,781 with a category attached, or 60.5%. 32 manufacturers reported payments, led by Inari Medical, Inc. at 42.8% of the total. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 386 payments — averaging $1053.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$174K
- Microvention, Inc.$91K
- Sirtex Medical Inc$73K
- Boston Scientific$24K
- Angiodynamics, Inc.$8K
- Siemens Medical Solutions USA, Inc.$7K
- plus $29K from 26 others
Across 289 payments — averaging $1716.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$193K
- Vesper Medical$141K
- Merit Medical Systems Inc$89K
- Philips North America LLC$36K
- Microvention, Inc.$32K
- Stryker$4K
What the payments were for
- Consulting fees$246,29661%
- Speaking & faculty fees$113,42828%
- Travel & lodging$26,8847%
- Food & beverage$11,9083%
- Other$8,2672%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 113 | $174,014 |
| Microvention, Inc. | 36 | $90,992 |
| Sirtex Medical Inc | 53 | $73,241 |
| Boston Scientific | 48 | $23,851 |
| Angiodynamics, Inc. | 3 | $8,281 |
| Siemens Medical Solutions USA, Inc. | 6 | $7,104 |
| Abbott | 10 | $6,717 |
| Walk Vascular, LLC | 5 | $3,000 |
| Stryker | 28 | $2,862 |
| Vesper Medical | 4 | $2,523 |
| Penumbra, Inc. | 13 | $2,348 |
| Bard Peripheral Vascular, Inc. | 9 | $2,281 |
| Medtronic(3 entities) | 18 | $2,252 |
| Devoro Medical Inc. | 2 | $2,000 |
| Innova Vascular Inc. | 2 | $1,426 |
| Guerbet LLC | 1 | $1,141 |
| Biocompatibles, Inc. | 3 | $1,077 |
| Balt USA, LLC | 10 | $541 |
| Imperative Care, Inc | 3 | $253 |
| Shockwave Medical, Inc | 1 | $164 |
| Cardiovascular Systems Inc. | 2 | $155 |
| E.r. Squibb & Sons, L.L.C. | 3 | $142 |
| Cagent Vascular Inc | 1 | $104 |
| Silk Road Medical, Inc. | 2 | $75 |
| Johnson & Johnson(2 entities) | 3 | $56 |
| Merz North America, Inc. | 1 | $47 |
| Terumo Medical Corporation | 1 | $37 |
| Philips North America LLC | 1 | $23 |
| Nevro Corp. | 1 | $23 |
| Reflow Medical Inc | 1 | $20 |
| LNHC, Inc | 1 | $17 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$174,431
- FLOWTRIEVER CATHETER, S$105,359
- SIR-Spheres Microspheres$50,962
- FlowTriever$33,515
- ClotTriever$33,515
- LAVA LES (Liquid Embolic System)$21,339
- Auryon Laser System 100-120 Vac$8,267
- GENERAL - THERAPIES$5,082
- Indigo$2,944
- GENERAL THROMBECTOMY$2,775
- XIENCE V$2,750
- DUO Venous Stent System$2,500
- ERIC RETRIEVAL DEVICE$2,407
- XIENCE SIERRA$2,250
- JETi Peripheral Catheter$2,100
- GENERAL VASCULAR INTERVENTION$2,050
- WOLF$2,000
- THERASPHERE-BIO$1,697
- ESPRIT$1,320
- JETi All In One Non-Sterile Kit$1,200
How this compares
$406,781 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 40 | $34,935 |
| ClopidogrelClopidogrel Bisulfate | 17 | $108 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Orange
- Mahmood RazaviOrange$2.4M
- Kevin BurnsOrange$1.1M
- Nadine Abi-JaoudehOrange$105K
- Keith TerasakiLos Angeles$1.7M
- Bart DolmatchMountain View$1.7M
- Edward LeeLos Angeles$1.4M
- Alexander MisonoNewport Beach$1.3M
- Siddharth PadiaLos Angeles$960K
- Satoshi TateshimaLos Angeles$764K
- Blaise BaxterSan Francisco$757K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.